Which non-steroidal anti-inflammatory drug should be used in patients with increased risk of gastrointestinal toxicity?

Abstract

Article comments results of clinical study CONDOR aimed at comparison of gastrointestinal adverse effects in patients treated with celecoxib as compared with subjects taking non-selective NSAID combined with proton pump inhibitors. The study confirmed significantly better outcome in patients treated with celcoxib in terms of adverse effects.

Keywords

• anti-inflammatory drug
• gastrointestinal toxicity
• inflammatory bowel disease